Detalles de la búsqueda
1.
A Pooled Analysis of 3 Phase II Trials of Salvage Nivolumab/Ipilimumab After Nivolumab in Renal Cell Carcinoma.
Oncologist
; 29(4): 324-331, 2024 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37950901
2.
Arterial Spin Labeled Perfusion MRI for the Evaluation of Response to Tyrosine Kinase Inhibition Therapy in Metastatic Renal Cell Carcinoma.
Radiology
; 298(2): 332-340, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33258745
3.
Racial differences in cardiopulmonary outcomes of hospitalized COVID-19 patients with acute kidney injury.
Rev Cardiovasc Med
; 22(4): 1667-1675, 2021 12 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-34957809
4.
A model combining clinical and genomic factors to predict response to PD-1/PD-L1 blockade in advanced urothelial carcinoma.
Br J Cancer
; 122(4): 555-563, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31857723
5.
Local Recurrence Following Resection of Intermediate-High Risk Nonmetastatic Renal Cell Carcinoma: An Anatomical Classification and Analysis of the ASSURE (ECOG-ACRIN E2805) Adjuvant Trial.
J Urol
; 203(4): 684-689, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31596672
6.
Incorporation of extracorporeal photopheresis into a reduced intensity conditioning regimen in myelodysplastic syndrome and aggressive lymphoma: results from ECOG 1402 and 1902.
Transfusion
; 60(8): 1867-1872, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32654201
7.
Long-Term Follow-Up of the RESORT Study (E4402): A Randomized Phase III Comparison of Two Different Rituximab Dosing Strategies for Low-Tumor Burden Follicular Lymphoma.
J Clin Oncol
; 42(7): 774-778, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38194625
8.
Treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A).
J Immunother Cancer
; 12(4)2024 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38604810
9.
PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti-PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma Patients.
Clin Cancer Res
; 30(4): 803-813, 2024 02 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38060202
10.
A Cohort Study to Evaluate Genetic Predictors for Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS): Results from ECOG-ACRIN E1Z11.
Clin Cancer Res
; 2024 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38640040
11.
Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B).
J Immunother Cancer
; 11(3)2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36948504
12.
Phase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients With Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A).
J Clin Oncol
; 40(25): 2913-2923, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35442713
13.
Phase II Study of Taselisib in PIK3CA-Mutated Solid Tumors Other Than Breast and Squamous Lung Cancer: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol I.
JCO Precis Oncol
; 6: e2100424, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35138919
14.
Cardiovascular complications in COVID-19 patients with or without diabetes mellitus.
Endocrinol Diabetes Metab
; 4(2): e00218, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33614986
15.
Gene Expression Signature Correlates with Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with Everolimus Alone or with a Vascular Disrupting Agent.
Mol Cancer Ther
; 20(8): 1454-1461, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34108261
16.
Pre-existing cardiovascular disease, acute kidney injury, and cardiovascular outcomes in hospitalized blacks with COVID-19 infection.
Am J Cardiovasc Dis
; 11(2): 212-221, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34084656
17.
Predicting Disease Recurrence, Early Progression, and Overall Survival Following Surgical Resection for High-risk Localized and Locally Advanced Renal Cell Carcinoma.
Eur Urol
; 80(1): 20-31, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33707112
18.
Smoking Behavior in Patients With Early-Stage NSCLC: A Report From ECOG-ACRIN 1505 Trial.
J Thorac Oncol
; 16(6): 960-967, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33539971
19.
Treatment-free Survival after Immune Checkpoint Inhibitor Therapy versus Targeted Therapy for Advanced Renal Cell Carcinoma: 42-Month Results of the CheckMate 214 Trial.
Clin Cancer Res
; 27(24): 6687-6695, 2021 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34759043
20.
KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD1.
Cancer Immunol Res
; 9(2): 156-169, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33229411